FOR THE FOURTH CONSECUTIVE YEAR, THE CETILAR® BRAND WILL FEATURE ON BOTH THE TWO OFFICIAL FERRARI 499P HYPERCARS AND THE RACING SUITS OF THE SIX PRANCING HORSE DRIVERS.
THE NEW OFFICIAL SEASON KICKS OFF ON APRIL 19 IN IMOLAPisa, 9 April 2026 - Pharmanutra S.p.A. (MTA; Ticker PHN), a company specialized in mineral-based nutritional supplements and medical devices for muscles and joints, announces the renewal of its partnership with Team - AF Corse through 2026.
The company, founded in 2003 by brothers Andrea and Roberto Lacorte and fully committed to the world of sports through a series of major sponsorships and partnerships, will be present for the fourth consecutive year on the two official Ferrari 499P Hypercars competing in the FIA WEC, the World Endurance Championship, confirming a strongly consolidated relationship with Team Ferrari - AF Corse. A winning partnership that has yielded exceptional results over the past three years: from the double victory at the 24 Hours of Le Mans - in 2023 with the No. 51 499P (Pier Guidi, Giovinazzi, Calado) and in 2024 with its sister car, number 50 (Fuoco, Molina, Nielsen) - to the Drivers' and Manufacturers' World Championships won last year following a triumphant season in which the official Ferrari 499Ps left their rivals in the dust.
For this World Endurance Championship as well, which will officially kick off in Imola, Italy, on Sunday, April 19, with the "6 Hours of Imola" (the Prologue takes place on Tuesday, April 14) and will conclude in Bahrain in November, following races in Spa (Belgium), Le Mans (France), São Paulo (Brazil), Austin (USA), Fuji (Japan), and Qatar, Pharmanutra will support Team Ferrari - AF Corse with its Cetilar® brand, featured on both official 499P cars and on the suits of the six official drivers of the Prancing Horse.
Cetilar® is a line of products based on cetylated esters designed to support muscle and joint health, available in Cream, Patch, Tape, and Gold formulations - but that's not all. For the past three years, Cetilar® has also included a Nutrition line dedicated to sports nutrition: a range of supplements and functional foods specifically designed to support athletes' physical performance by providing optimal energy, hydration, and recovery. Thanks to their scientifically advanced formulation, Cetilar® Nutrition products-
the Official Nutrition Partner of the Giro d'Italia cycling race-provide the ideal support for tackling major sporting challenges such as the FIA WEC endurance races, which require sustained performance and careful management of energy reserves.
Roberto Lacorte (Vice President and CEO of Pharmanutra S.p.A.) states: "We have embraced and supported the Ferrari Team - AF Corse Hypercar project since its inception, and we are therefore very pleased that our commitment is being renewed for this year as well, because it is a challenge in which we strongly believe and which, over the past three years, has brought us incredible satisfaction, from the double victory at Le Mans to last year's World Championship title. I'd like to point out that our involvement in this project isn't limited to sponsorship the Cetilar® brand, but also extends to close medical and scientific collaboration with Med-Ex, the leading organization that has worked alongside Ferrari for many years, handling the physical conditioning and all health-related aspects for the team members, using our products."
Amato Ferrari (Founder of AF Corse) adds: "Pharmanutra is a company that embodies Italian excellence. We are proud to have them by our side once again and to be able to take to the track with the Cetilar brand on the #50 and #51 499P cars. Their products make a tangible contribution to improving the performance and endurance of our team members. In endurance races, every detail can make a difference: being able to rely on natural-based solutions, such as those developed by Pharmanutra, undoubtedly represents an added value that should not be underestimated." Pharmanutra S.p.A.Founded in 2003 in Pisa by Andrea and Roberto Lacorte, Pharmanutra is the holding company of an international Group engaged in the research, development, and commercialization of nutritional supplements, medical devices, and patented raw materials. A leader in iron-based supplements through its Sucrosomial® Technology (SiderAL® and Apportal®), and an emerging player in medical devices for mobility (Cetilar®), the Group internally manages the entire value chain and holds a solid portfolio of patents, brands, and clinical evidence.
Pharmanutra operates in over 80 countries, with subsidiaries in the USA and Spain, and also includes Akern S.r.l. (bioimpedance analysis) and Athletica Cetilar S.r.l. (sports medicine).
PharmanutraGroup.com Pharmanutra.it
For further information:
Pharmanutra S.p.A. Press Office - Spriano Communication & PartnersVia Campodavela 1 - 56122 Pisa
Tel. +39 050 7846500
investorrelation@pharmanutra.it
IR DirectorSimona Del Re s.delre@pharmanutra.it
Via Santa Radegonda, 16 - 20121 Milano Tel. +39 02 83635708
Matteo Russo mrusso@sprianocommunication.com Cristina Tronconi ctronconi@sprianocommunication.com
Internal Press Officepress@calabughi.com